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The prewarm (PW) method is useful for detecting and identifying 
clinically significant antibodies that bind to red blood cells 
and complement at 37°C and for avoiding antibodies that 
bind at temperatures less than 37°C. Antibodies that bind at 
temperatures less than 37°C are often cold autoantibodies 
that may be present in the serum of healthy individuals and 
are usually not clinically significant. The PW method is useful 
when these cold autoantibodies have a wide thermal range and 
interfere with standard testing methods by reacting at the 37°C 
and antihuman globulin test phases. When using the PW method, 
it is important to identify underlying, potentially clinically 
significant alloantibodies during pretransfusion testing to ensure 
the most appropriate component will be selected for transfusion. 
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Principle
The prewarm (PW) method can be used to detect and 
identify red blood cell (RBC) antibodies that bind to antigens 
only at 37°C.1 The PW method is often used in the presence 
of cold autoantibodies that interfere with standard testing 
methods and potentially mask the presence of underlying 
clinically significant alloantibodies. By prewarming reagents 
and patient serum/plasma to 37°C before testing, cold 
antibodies are prevented from binding, allowing for the 
identification of clinically significant antibodies that bind 
at 37°C and/or at the antihuman globulin (AHG) phase.2 
Reactions and serologic readings take place at 37°C. Hence, 
antibodies that react at less than 37°C are usually not 
detectable when using the PW method; antibodies that react 
at the AHG phase are detectable. Prewarming of the patient’s 
serum/plasma and the test RBCs separately prevents binding 
of cold-reactive antibodies once reagents and serum/plasma 
are combined. Anti-IgG is used rather than polyspecific AHG 
to help circumvent reactions with RBC-bound complement.
Applications
The PW method is most frequently used to identify 
underlying antibodies in the presence of strong cold 
autoantibodies that react at the 37°C and AHG phases of 
testing. Cold autoantibodies are usually of the IgM isotype and 
not clinically significant. The most frequently encountered 
Reagents/Supplies
Reagents Supplies
• Normal saline or PBS
• Anti-IgG
• Group O reagent RBCs for 
antibody detection
• Patient RBCs for autocontrol
• IgG-coated RBCs
• Group A1, A2, B, and O reagent 
RBCs
• 37°C incubator





PBS = phosphate-buffered saline; RBCs = red blood cells.
Procedural Steps
• Prewarm saline/PBS to 37°C.
• Label one test tube for each reagent RBC and A/C.
• To each labeled tube, add one drop of the respective reagent 
RBCs or A/C.
• Add an adequate volume of patient serum/plasma and a pipette to 
an appropriately labeled tube.
• Incubate tubes at 37°C for 5–10 minutes.
• Using 37°C pipette, add two drops of prewarmed patient serum/
plasma to each prewarmed RBC tube and mix.
• Incubate at 37°C for 30–60 minutes.
• Wash tubes four times with 37°C saline/PBS.
• Add anti-IgG in accordance with manufacturer’s directions.
• Centrifuge and observe for agglutination; grade and record results.
• Add IgG-coated RBCs to negative reactions.
PBS = phosphate-buffered saline; RBC = red blood cell; A/C = 
autocontrol.
IMMUNOHEMATOLOGY, Volume 34, Number 4, 2018 149
cold autoantibody is anti-I. Anti-I is common even in the 
serum of healthy individuals and reacts strongly at 4°C. 
Other common cold autoantibodies include anti-IH, which 
is usually found in the serum of group A1 individuals and 
reacts strongly with group O and A2 RBCs, and anti-i, which 
is less common and may be seen in the serum of patients 
with infectious mononucleosis. These specificities are usually 
identified with a panel of RBCs tested after a 4°C incubation.1 
Once an antibody has been identified as one of these clinically 
insignificant specificities, steps should be taken to eliminate 
such reactivity in the AHG phase, and the PW method is one 
way to accomplish this.
The PW method can also be used to determine whether 
an antibody that reacts optimally at colder temperatures has 
a wide thermal range and thus may need to be considered 
clinically significant or to be identified as the cause of reactivity 
observed at 37°C. Cold autoantibodies with a wide thermal 
range may be found with cold agglutinin syndrome. In this 
setting, the antibodies bind complement and are considered 
clinically significant.
Cold autoantibodies can also interfere with serum/
plasma testing or reverse group testing causing blood group 
discrepancies. A modified PW method described subsequently 
can be used to resolve ABO group discrepancies caused by 
cold autoantibodies.
Procedure 
PW Method for Antibody Detection/Identification
Prewarm a container of saline/phosphate-buffered saline 
to 37°C. Label one test tube for each reagent/donor RBC 
sample to be tested, including a test tube for an autologous 
control (autocontrol). Label one test tube that will contain an 
adequate volume of patient serum/plasma for all anticipated 
testing and a transfer pipette. Prepare a 2–5 percent RBC 
suspension for each reagent or donor RBC sample and the 
autocontrol. Add one drop of each 2–5 percent RBC suspension 
to its respectively labeled tube. Place the tubes containing the 
RBC suspensions and the patient plasma/serum (at least two 
drops for each RBC to be tested and two additional drops) in a 
37°C incubator for 5–10 minutes. Leave the transfer pipette in 
the tube containing the plasma to prewarm as well. Using the 
prewarmed pipette, transfer two drops of plasma to each tube 
containing prewarmed RBCs to be tested. Mix gently without 
removing from the incubator. Incubate at 37°C for 30–60 
minutes. Wash and then centrifuge the tubes three to four 
times using 37°C warmed saline. Add anti-IgG according to 
the manufacturer’s instructions. Centrifuge and then observe 
for agglutination. Grade reactions accordingly and record 
results. Confirm that negative AHG reactions are valid with 
the use of IgG-coated RBCs.
Prewarmed Serum Group Determination
Add one drop of each RBC to be tested (group A1, A2 (if 
desired), B, and O RBCs for a control) to appropriately labeled 
tubes. Add an adequate amount of patient serum/plasma to a 
separate labeled tube (at least two drops for each RBC to be 
tested). Warm the tubes at 37°C for 5–10 minutes, leaving the 
transfer pipette in the tube containing patient serum/plasma. 
Using the prewarmed 37°C pipette, add two drops of patient 
serum/plasma to each of the tubes containing reagent RBCs 
and gently mix. Incubate the tubes at 37°C for 1 hour. Remove 
the tubes and examine the settled cells for agglutination (do 
not centrifuge).
Limitations
The PW method should be used with caution, since 
decreased (clinically significant) antibody reactivity has been 
reported, and some weak antibodies can be missed.3 Using 
room temperature saline to perform washes after incubation 
may help to avoid the elution of clinically significant 
antibodies, although strongly reactive cold autoantibodies 
may still react.1 The PW method should not be used when the 
specificity of the antibody has not been determined, especially 
when the autocontrol tests are negative. Clinically significant 
alloantibodies such as anti-I, anti-P, and anti-Vel have been 
mistaken for the clinically insignificant cold-reactive antibody 
after the use of the PW method.4 The PW method may not detect 
potentially significant complement-binding alloantibodies or 
hemolysis and will not detect antibodies that bind at less than 
37°C. Separate tubes may be set up for a direct reading at 37°C 
to observe for hemolysis and agglutination.4 Allowing these 
separate tubes to incubate at 37°C for 60–120 minutes and 
examining the settled RBCs for agglutination by resuspending 
the cell button may help detect these antibodies if desired.5 
When using the PW method for reverse group testing, some 
weak anti-A and anti-B may not be detected.
Quality Control
Quality control should be performed on all reagents and 
equipment used per the manufacturer’s instructions for day of 
use. IgG-coated RBCs are used to confirm all negative AHG 
Prewarm method
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reactions. If no agglutination is observed after the addition 
of IgG-coated cells, the indirect antiglobulin test is invalid. If 
agglutination is observed with the group O RBC sample when 
performing reverse group testing, the test is invalid, and no 
conclusion can be drawn regarding the ABO group.
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